Independent Advisor Alliance purchased a new stake in Amentum Holdings, Inc. (NYSE:AMTM – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,780 shares of the company’s stock, valued at approximately $283,000.
Several other hedge funds have also added to or reduced their stakes in AMTM. Arrow Financial Corp bought a new position in shares of Amentum in the third quarter valued at about $26,000. US Bancorp DE acquired a new stake in Amentum during the third quarter worth approximately $30,000. Signaturefd LLC bought a new stake in shares of Amentum during the third quarter worth approximately $33,000. HM Payson & Co. bought a new stake in shares of Amentum during the third quarter worth approximately $38,000. Finally, Studio Investment Management LLC acquired a new position in shares of Amentum in the third quarter valued at approximately $42,000.
Analysts Set New Price Targets
AMTM has been the subject of several recent research reports. Truist Financial initiated coverage on Amentum in a research note on Monday, October 14th. They issued a “buy” rating and a $31.00 price target for the company. Raymond James began coverage on shares of Amentum in a research note on Thursday, November 21st. They issued an “outperform” rating and a $30.00 price target on the stock.
Amentum Stock Performance
Shares of AMTM stock opened at $23.90 on Friday. Amentum Holdings, Inc. has a 1 year low of $21.24 and a 1 year high of $34.50.
Amentum Profile
Amentum Holdings, Inc provides engineering and technology solutions to address challenges in science, security, and sustainability. It serves various markets, such as energy and environment, space, intelligence, defense, civilian, commercial, and international markets. The company was incorporated in 2010 and is headquatered in Chantilly, Virginia.
Featured Stories
- Five stocks we like better than Amentum
- How to Invest in Small Cap StocksĀ
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- EV Stocks and How to Profit from Them
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding AMTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amentum Holdings, Inc. (NYSE:AMTM – Free Report).
Receive News & Ratings for Amentum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amentum and related companies with MarketBeat.com's FREE daily email newsletter.